Arboretum

New approach to precision medicine for common diseases, bringing smarter diagnostics, efficient trials, and better care for millions.

Sectors

Healthtech + Services
Life Sciences

Status

Private

Location

Cambridge, MA

Initial Investment

2024
New approach to precision medicine for common diseases, bringing smarter diagnostics, efficient trials, and better care for millions.

A next-generation molecular information company with a mission to make precision medicine a reality for some of the most common diseases that impact patients around the world. Founded by leaders in data science from the Broad Institute, Arboretum’s approach integrates AI and genetic testing to expand access to genomic medicine for patients and enable recruitment of genomically profiled patients for clinical research partners.